Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.

Elterman, Dean Sol

Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. [electronic resource] - The Journal of urology May 2010 - 2085-9 p. digital

Publication Type: Comparative Study; Journal Article

1527-3792

10.1016/j.juro.2009.12.097 doi


Administration, Oral
Adrenergic alpha-Antagonists--chemistry
Azasteroids--chemistry
Capsules
Cholestenone 5 alpha-Reductase--antagonists & inhibitors
Chromatography, High Pressure Liquid
Doxazosin--chemistry
Drug Contamination
Dutasteride
Enzyme Inhibitors--chemistry
Finasteride--chemistry
Humans
Male
Phytotherapy
Prazosin--analogs & derivatives
Prostatic Hyperplasia--drug therapy
Quinazolines--chemistry
Sulfonamides--chemistry
Tablets
Tamsulosin